 |
 |
|||||
  |
 |
 |
 |
 |
 |
|
 |
|
Jeremiah Hall is a communications professional with nearly 15 years of healthcare experience. As a senior vice president with FKH, Jeremiah provides clients with a broad range of capabilities, including investor relations, issues management, product marketing, media relations, branding and executive visibility. Jeremiah oversees the firm's West Coast operations from its San Francisco office. Jeremiah has particular expertise in building corporate communications programs for small to mid-sized life science companies, where he employs a range of creative, thoughtful strategies for translating a client's story to its many audiences. His biotechnology clients have included BioMarin, Cell Genesys, Cell Therapeutics, Cerus, Tanox and Tularik. Additionally he?s supported a number of economic development organizations including BayBio, BioHouston and Invest Australia. Jeremiah has also worked with numerous pharmaceutical and large biotechnology firms, including Abbott, GlaxoSmithKline, Chiron and Ortho-Biotech. His knowledge of such companies has been invaluable in helping emerging clients craft programs that speak directly to potential pharmaceutical partners. Jeremiah has also led numerous clients through crisis management, repositioning and turnaround projects. His work has won several industry awards for competitive positioning, crisis management and media relations. And he frequently speaks and writes on communications issues for industry associations such as BioE2E and Bay Bio. Beginning his career as a journalist, Jeremiah later joined the Federal Emergency Management Agency where he acted as the organization's spokesman and crisis specialist. He holds a bachelor's degree in journalism from the University of San Francisco. He has also completed the Global BioExecutive Program at University of California, Berkeley Haas School of Business.
|
|
||||
 |
||||||
|
|
|
|
|
